Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.11198 | 46 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.09267 | 47 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.09674 | 47 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.98983 | 45 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.01721 | 46 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.19397 | 47 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.18125 | 47 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.11 | 47 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.04405 | 45 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.05755 | 46 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.31216 | 54 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.03574 | 46 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.14133 | 48 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.08461 | 46 |